*	OR T3 T2
R1	Has_qualifier Arg1:T1 Arg2:T3	
*	OR T6 T5
R2	Subsumes Arg1:T7 Arg2:T8	
R3	Has_qualifier Arg1:T6 Arg2:T7	
*	OR T11 T12
R4	Has_multiplier Arg1:T10 Arg2:T11	
R5	Has_qualifier Arg1:T14 Arg2:T15	
R6	Has_qualifier Arg1:T14 Arg2:T10	
*	OR T18 T17
R7	Has_value Arg1:T16 Arg2:T18	
R8	Has_index Arg1:T21 Arg2:T22	
*	OR T25 T24
R9	Has_value Arg1:T23 Arg2:T25	
R10	Has_temporal Arg1:T23 Arg2:T21	
R11	Subsumes Arg1:T28 Arg2:T29	
R12	Has_value Arg1:T28 Arg2:T30	
R13	Subsumes Arg1:T31 Arg2:T32	
*	OR T34 T33
R14	Has_index Arg1:T36 Arg2:T37	
*	OR T39 T40
R15	Has_negation Arg1:T39 Arg2:T38	
R16	Has_value Arg1:T31 Arg2:T34	
R17	Has_temporal Arg1:T31 Arg2:T36	
R18	Has_temporal Arg1:T39 Arg2:T36	
R19	Subsumes Arg1:T42 Arg2:T43	
*	OR T45 T44
R20	Has_negation Arg1:T48 Arg2:T47	
R21	Has_index Arg1:T49 Arg2:T50	
R22	Has_value Arg1:T42 Arg2:T45	
R23	Has_temporal Arg1:T42 Arg2:T49	
R24	Has_temporal Arg1:T48 Arg2:T49	
*	OR T52 T53
R25	Has_value Arg1:T51 Arg2:T52	
*	OR T57 T56
R26	Has_value Arg1:T55 Arg2:T57	
*	OR T60 T62
R27	Has_value Arg1:T59 Arg2:T60	
*	OR T66 T65
*	OR T67 T68
R28	Has_value Arg1:T64 Arg2:T66	
*	OR T72 T71
R29	Has_value Arg1:T70 Arg2:T72	
*	OR T59 T64
R30	AND Arg1:T76 Arg2:T77	
*	OR T79 T78
R31	Has_value Arg1:T79 Arg2:T81	
*	OR T86 T89 T87 T88
R32	multi Arg1:T85 Arg2:T86	
R33	Has_temporal Arg1:T82 Arg2:T84	
R34	Has_qualifier Arg1:T91 Arg2:T83	
R35	AND Arg1:T92 Arg2:T91	
R36	Has_value Arg1:T93 Arg2:T27	
R37	Has_index Arg1:T84 Arg2:T85	
R38	Has_value Arg1:T64 Arg2:T67	
*	OR T61 T64
T1	Condition 68 73	NSCLC
T2	Qualifier 34 54	cytologically proven
T3	Qualifier 16 30;48 54	histologically proven
T5	Condition 107 112;121 133	stage IIIb disease
T6	Condition 107 117;126 133	stage IIIa disease
T7	Qualifier 75 87	Unresectable
T8	Qualifier 89 105	locally advanced
T10	Qualifier 224 233	esophagus
T11	Multiplier 188 200;213 215	greater than 30
T12	Multiplier 204 216	equal to 30%
T14	Measurement 143 155	radiotherapy
T15	Qualifier 135 142	Initial
T16	Observation 235 250	Life expectancy
T17	Value 267 284	equal to 6 months
T18	Value 251 263;276 284	greater than 6 months
T20	Condition 378 396	Measurable disease
T21	Temporal 341 376	3 months before study randomization
T22	Reference_point 357 376	study randomization
T23	Measurement 286 307	Estimated weight loss
T24	Value 321 333	equal to 10%
T25	Value 308 317;330 333	less than 10%
T28	Measurement 424 458;466 484	Eastern Cooperative Oncology Group performance status
T29	Measurement 460 464	ECOG
T30	Value 488 493	0 - 2
T31	Measurement 495 505	Hemoglobin
T32	Measurement 507 510	hgb
T33	Value 528 544	equal to 10 g/dL
T34	Value 512 524;537 544	greater than 10 g/dL
T36	Temporal 596 637	in the 4 weeks before study randomization
T37	Reference_point 618 637	study randomization
T38	Negation 545 552	without
T39	Observation 553 574	transfusional support
T40	Observation 578 595	growth factor use
T42	Measurement 639 664	Absolute neutrophil count
T43	Measurement 666 669	ANC
T44	Value 687 708	equal to 1.5 x 10^9/L
T45	Value 671 683;696 708	greater than 1.5 x 10^9/L
T47	Negation 709 716	without
T48	Observation 717 734	growth factor use
T49	Temporal 735 776	in the 2 weeks before study randomization
T50	Reference_point 757 776	study randomization
T51	Measurement 778 792	Platelet count
T52	Value 793 805;818 830	greater than 100 x 10^9/L
T53	Value 809 830	equal to 100 x 10^9/L
T55	Measurement 832 847	Serum bilirubin
T56	Value 861 917	equal to 1.5 x institutional upper limit of normal (ULN)
T57	Value 848 857;870 917	less than 1.5 x institutional upper limit of normal (ULN)
T59	Measurement 919 935	Serum creatinine
T60	Value 949 967	equal to 2.0 mg/dL
T61	Value 936 945	less than
T62	Value 958 967	2.0 mg/dL
T64	Measurement 991 1007	serum creatinine
T65	Value 1024 1036;1067 1072	equal to 1.4 mg/dL
T66	Value 1008 1020;1033 1036;1067 1072	greater than 1.4 mg/dL
T67	Value 1041 1050;1063 1072	less than 2.0 mg/dL
T68	Value 1054 1072	equal to 2.0 mg/dL
T70	Measurement 1092 1128	24-hour urinary creatinine clearance
T71	Value 1145 1163	equal to 50 mL/min
T72	Value 1129 1141;1154 1163	greater than 50 mL/min
T76	Person 1166 1173	Females
T77	Condition 1177 1199	childbearing potential
T78	Measurement 1219 1239	urine pregnancy test
T79	Measurement 1210 1215;1225 1239	serum pregnancy test
T81	Value 1201 1209	negative
T82	Observation 1267 1283	informed consent
T84	Temporal 1284 1389	before participating in any study-specific procedure, randomization, or receiving investigational product
T85	Reference_point 1291 1389	participating in any study-specific procedure, randomization, or receiving investigational product
T86	Qualifier 1312 1326	study-specific
T87	Procedure 1327 1336	procedure
T88	Procedure 1338 1351	randomization
T89	Drug 1366 1389	investigational product
T83	Qualifier 1453 1461	adequate
T91	Procedure 1462 1483	contraception methods
T92	Condition 1406 1429	reproductive capability
T27	Value 398 406;414 422	18 years or older
T93	Person 410 413	age
